Ieq Capital LLC Makes New $2.27 Million Investment in Teladoc Health, Inc. $TDOC

Ieq Capital LLC purchased a new stake in Teladoc Health, Inc. (NYSE:TDOC) in the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 268,062 shares of the health services provider’s stock, valued at approximately $2,273,000. Ieq Capital LLC owned approximately 0.15% of Teladoc Health at the end of the most recent quarter.

Several other institutional investors have also made changes to their positions in TDOC. Allworth Financial LP acquired a new stake in shares of Teladoc Health during the 2nd quarter worth $25,000. IFP Advisors Inc raised its stake in Teladoc Health by 412.1% in the third quarter. IFP Advisors Inc now owns 3,989 shares of the health services provider’s stock valued at $31,000 after purchasing an additional 3,210 shares in the last quarter. PNC Financial Services Group Inc. lifted its position in Teladoc Health by 177.7% during the fourth quarter. PNC Financial Services Group Inc. now owns 4,391 shares of the health services provider’s stock worth $31,000 after purchasing an additional 2,810 shares during the period. EverSource Wealth Advisors LLC lifted its position in Teladoc Health by 694.5% during the first quarter. EverSource Wealth Advisors LLC now owns 5,657 shares of the health services provider’s stock worth $31,000 after purchasing an additional 4,945 shares during the period. Finally, International Assets Investment Management LLC acquired a new stake in Teladoc Health during the fourth quarter worth about $45,000. 76.82% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Teladoc Health

In other Teladoc Health news, insider Fernando M. Rodrigues sold 5,677 shares of the company’s stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total value of $43,315.51. Following the completion of the transaction, the insider directly owned 9,572 shares in the company, valued at approximately $73,034.36. This represents a 37.23% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, insider Carlos Nueno sold 6,196 shares of the firm’s stock in a transaction on Tuesday, June 2nd. The shares were sold at an average price of $7.63, for a total transaction of $47,275.48. Following the transaction, the insider directly owned 57,671 shares of the company’s stock, valued at $440,029.73. The trade was a 9.70% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 39,195 shares of company stock worth $299,058 in the last 90 days. Corporate insiders own 0.70% of the company’s stock.

Analyst Ratings Changes

TDOC has been the subject of several analyst reports. Bank of America boosted their target price on shares of Teladoc Health from $9.00 to $10.50 and gave the company a “buy” rating in a research report on Tuesday, July 7th. Citigroup decreased their price objective on shares of Teladoc Health from $11.00 to $7.50 and set a “neutral” rating on the stock in a research note on Monday, August 3rd. Weiss Ratings restated a “sell (d-)” rating on shares of Teladoc Health in a research note on Wednesday, August 19th. Finally, Canaccord Genuity Group reduced their target price on Teladoc Health from $11.00 to $10.00 and set a “buy” rating on the stock in a report on Thursday, July 30th. Five investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Teladoc Health presently has a consensus rating of “Hold” and a consensus price target of $7.54.

Teladoc Health Stock Performance

Shares of TDOC opened at $6.21 on Wednesday. Teladoc Health, Inc. has a 52 week low of $4.40 and a 52 week high of $9.89. The stock has a market capitalization of $1.13 billion, a price-to-earnings ratio of -6.27 and a beta of 2.12. The stock has a fifty day moving average of $8.03 and a 200-day moving average of $6.62.

Teladoc Health (NYSE:TDOC) last issued its quarterly earnings data on Wednesday, July 29th. The health services provider reported ($0.21) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.25) by $0.04. Teladoc Health had a negative return on equity of 12.15% and a negative net margin of 7.13%.The business had revenue of $606.93 million for the quarter, compared to analyst estimates of $615.44 million. During the same quarter in the previous year, the company posted ($0.19) EPS. Teladoc Health’s quarterly revenue was down 4.0% compared to the same quarter last year. Teladoc Health has set its Q3 2026 guidance at -0.300–0.200 EPS and its FY 2026 guidance at -1.000–0.750 EPS. As a group, equities analysts forecast that Teladoc Health, Inc. will post -0.89 EPS for the current year.

About Teladoc Health

Teladoc Health, Inc is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease.